TrialRMD open2024

PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs.

Celine J van de Laar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.